Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Clinical trial NCT07296484 · RECRUITING

Trial details

NCT number: NCT07296484
Sponsor: Sparrow Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Cortisol Excess

Start date: 2025-11-29
Primary completion: 2027-12-31
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.